154 related articles for article (PubMed ID: 8978500)
1. Genetic elevation of monoamine oxidase levels in dopaminergic PC12 cells results in increased free radical damage and sensitivity to MPTP.
Wei Q; Yeung M; Jurma OP; Andersen JK
J Neurosci Res; 1996 Dec; 46(6):666-73. PubMed ID: 8978500
[TBL] [Abstract][Full Text] [Related]
2. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
3. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
Basma AN; Heikkila RE; Nicklas WJ; Giovanni A; Geller HM
J Neurochem; 1990 Sep; 55(3):870-7. PubMed ID: 2384758
[TBL] [Abstract][Full Text] [Related]
4. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
Fonck C; Baudry M
Brain Res; 2001 Jun; 905(1-2):199-206. PubMed ID: 11423095
[TBL] [Abstract][Full Text] [Related]
5. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
Finnegan KT; Irwin I; Delanney LE; Langston JW
J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
[TBL] [Abstract][Full Text] [Related]
6. SKF-38393, a dopamine receptor agonist, attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
Muralikrishnan D; Ebadi M
Brain Res; 2001 Feb; 892(2):241-7. PubMed ID: 11172770
[TBL] [Abstract][Full Text] [Related]
7. Toxicity of MPTP and structural analogs in clonal cell lines of neuronal origin expressing B type monoamine oxidase activity.
Buckman TD
Mol Chem Neuropathol; 1991 Oct; 15(2):87-102. PubMed ID: 1776993
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
Fuller RW; Robertson DW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity.
Hom DG; Jiang D; Hong EJ; Mo JQ; Andersen JK
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):154-60. PubMed ID: 9191089
[TBL] [Abstract][Full Text] [Related]
10. Distinct structure and activity of monoamine oxidase in the brain of zebrafish (Danio rerio).
Anichtchik O; Sallinen V; Peitsaro N; Panula P
J Comp Neurol; 2006 Oct; 498(5):593-610. PubMed ID: 16917825
[TBL] [Abstract][Full Text] [Related]
11. Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
Itzhak Y; Mash D; Zhang SH; Stein I
Mol Pharmacol; 1991 Mar; 39(3):385-93. PubMed ID: 1848660
[TBL] [Abstract][Full Text] [Related]
12. Neural progenitor cells are protected against MPTP by MAO-B inhibitors.
He XJ; Uetsuka K; Nakayama H
Neurotoxicology; 2008 Nov; 29(6):1141-6. PubMed ID: 18606181
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
Wu WR; Zhu XZ; Guan HJ; Wang RG; Ji XQ
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):146-50. PubMed ID: 10437162
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies.
Marongiu ME; Piccardi MP; Bernardi F; Corsini GU; Del Zompo M
Neurosci Lett; 1988 Dec; 94(3):349-54. PubMed ID: 3264604
[TBL] [Abstract][Full Text] [Related]
15. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
Herraiz T; Arán VJ; Guillén H
Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
[TBL] [Abstract][Full Text] [Related]
16. N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
Goldstein DS; Jinsmaa Y; Sullivan P; Sharabi Y
Neurochem Res; 2017 Nov; 42(11):3289-3295. PubMed ID: 28840582
[TBL] [Abstract][Full Text] [Related]
17. Suppression of hydroxyl radical formation by MAO inhibitors: a novel possible neuroprotective mechanism in dopaminergic neurotoxicity.
Chiueh CC; Huang SJ; Murphy DL
J Neural Transm Suppl; 1994; 41():189-96. PubMed ID: 7931226
[TBL] [Abstract][Full Text] [Related]
18. The role of MAO in MPTP toxicity--a review.
Glover V; Gibb C; Sandler M
J Neural Transm Suppl; 1986; 20():65-76. PubMed ID: 3091762
[TBL] [Abstract][Full Text] [Related]
19. 3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
Goldstein DS; Jinsmaa Y; Sullivan P; Holmes C; Kopin IJ; Sharabi Y
Neurochem Res; 2016 Sep; 41(9):2173-8. PubMed ID: 27220335
[TBL] [Abstract][Full Text] [Related]
20. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B.
Ito T; Suzuki K; Uchida K; Nakayama H
Exp Toxicol Pathol; 2012 Nov; 64(7-8):761-5. PubMed ID: 21324658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
